
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on August 12, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,569 cr
Turnover Ratio
14.27%
Expense Ratio
0.89%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -1.31%
- 1Y: 2.91%
- 3M: 4.81%
- 3Y: 23.32%
- 6M: 7.99%
- 5Y: 19.30%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
490.078 | 10.77% | 4,027 cr | 0.89% | - |
Other plans of Nippon India Pharma